Mustang Bio, Inc. (MBIO)
NASDAQ: MBIO · Real-Time Price · USD
0.9257
-0.0317 (-3.31%)
At close: Mar 3, 2026, 4:00 PM EST
0.8614
-0.0643 (-6.95%)
Pre-market: Mar 4, 2026, 4:00 AM EST
Mustang Bio Market Cap
Mustang Bio has a market cap or net worth of $6.76 million as of March 4, 2026. Its market cap has increased by 170.24% in one year.
Market Cap
6.76M
Enterprise Value
-12.23M
1-Year Change
170.24%
Ranking
Category
Stock Price
$0.93
Market Cap Chart
Since August 22, 2017, Mustang Bio's market cap has decreased from $257.00M to $6.76M, a decrease of -97.37%. That is a compound annual growth rate of -34.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 7.00M | -2.78% |
| Dec 31, 2025 | 7.20M | -15.29% |
| Dec 31, 2024 | 8.50M | -31.45% |
| Dec 29, 2023 | 12.40M | -70.75% |
| Dec 30, 2022 | 42.40M | -72.66% |
| Dec 31, 2021 | 155.10M | -37.18% |
| Dec 31, 2020 | 246.90M | 49.18% |
| Dec 31, 2019 | 165.50M | 106.36% |
| Dec 31, 2018 | 80.20M | -74.50% |
| Dec 29, 2017 | 314.50M | 22.37% |
| Aug 22, 2017 | 257.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aspire Biopharma Holdings | 7.39M |
| Quoin Pharmaceuticals | 7.33M |
| Alzamend Neuro | 7.15M |
| Addex Therapeutics | 7.08M |
| Theriva Biologics | 6.76M |
| Moolec Science | 6.72M |
| Aptevo Therapeutics | 6.65M |
| Immuron | 6.42M |